肌张力障碍
GTP环水解酶I
左旋多巴
帕金森病
生物蝶呤
四氢生物蝶呤
酪氨酸羟化酶
内分泌学
内科学
医学
心理学
多巴胺
精神科
帕金森病
疾病
一氧化氮
一氧化氮合酶
作者
Yoshiaki Furukawa,Mark Guttman,Yuji Tomizawa,Stephen J. Kish
出处
期刊:Springer eBooks
[Springer Nature]
日期:2021-10-03
卷期号:: 421-454
标识
DOI:10.1007/978-3-030-75898-1_24
摘要
Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of levodopa. Typically, DRD presents with gait disturbance due to foot dystonia, later development of parkinsonism, and characteristic diurnal fluctuation of symptoms. There are three known causative genes for DRD: (1) GCH1, coding for GTP cyclohydrolase 1 (GTPCH1) that catalyzes the rate-limiting step in tetrahydrobiopterin (BH4; the cofactor for tyrosine hydroxylase [TH]) biosynthesis; (2) TH, coding for TH in catecholamine biosynthesis; and (3) SPR, coding for sepiapterin reductase (SR), which is involved in the last step in BH4 biosynthesis. Many DRD patients have shown dominantly inherited GCH1 mutations (GTPCH1-deficient DRD; the major form of DRD), whereas a relatively small number of DRD patients have demonstrated recessively inherited TH mutations (TH-deficient DRD; the mild form of TH deficiency) or SPR mutations (SR-deficient DRD; the very mild form of SR deficiency). As clinical suspicion is a key to the diagnosis of DRD, physicians should know the broad phenotypic spectrum in DRD families. Furthermore, because (1) administration of levodopa and “5-hydroxytryptophan” is necessary for severe autosomal recessive SR deficiency, (2) administration of levodopa, 5-hydroxytryptophan, and “BH4” is indispensable for severe autosomal recessive GTPCH1 deficiency, and (3) very low-dose levodopa must be used initially for infantile-onset patients with autosomal recessive TH deficiency having overt delay in motor development, physicians should also know symptoms of these genetically related disorders. This chapter summarizes clinical features and advances in the genetics and biochemistry of DRD and related disorders.KeywordsDystoniaParkinsonismDopa-responsiveDYT5LevodopaStriatal dopamineTetrahydrobiopterinBiopterinNeopterinGTP cyclohydrolase 1Tyrosine hydroxylaseSepiapterin reductaseGCH1 geneTH geneSPR geneParkinson’s diseaseCerebral palsySpastic paraplegia
科研通智能强力驱动
Strongly Powered by AbleSci AI